Kwality [KPL] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Kwality Pharmaceuticals Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Kwality Pharmaceuticals Ltd. wins in 9 metrics, Sun Pharmaceutical Industries Ltd. wins in 10 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Kwality Pharmaceuticals Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 30.86 36.73 Kwality Pharmaceuticals Ltd.
Price-to-Book Ratio 6.02 5.15 Sun Pharmaceutical Industries Ltd.
Debt-to-Equity Ratio 38.29 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio 0.35 3.59 Kwality Pharmaceuticals Ltd.
EV/EBITDA 17.28 23.61 Kwality Pharmaceuticals Ltd.
Profit Margin (TTM) 12.25% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 20.79% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 20.79% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 15.19% 15.08% Kwality Pharmaceuticals Ltd.
Return on Assets (TTM) 8.91% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $277.15M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return 159.49% 7.25% Kwality Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 3.78 7.05 Kwality Pharmaceuticals Ltd.
Enterprise Value $18.21B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 3.95 6.66 Kwality Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 52.12% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $444 $237 Kwality Pharmaceuticals Ltd.
Earnings per Share (Diluted) $54.54 $45.46 Kwality Pharmaceuticals Ltd.
Beta (Stock Volatility) 0.13 0.11 Sun Pharmaceutical Industries Ltd.

Kwality Pharmaceuticals Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

KPL
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kwality Pharmaceuticals Ltd.2.22%6.00%38.44%51.48%148.86%103.68%
Sun Pharmaceutical Industries Ltd.-0.08%-2.77%-1.84%2.13%-0.53%4.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kwality Pharmaceuticals Ltd.159.49%686.37%2,110.86%10,168.22%10,168.22%10,168.22%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Kwality Pharmaceuticals Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricKPLSUNPHARMA
Market Information
Market Cap i₹17.47B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i28,8973,903,142
90 Day Avg. Volume i30,3283,253,866
Last Close₹2,344.90₹1,788.50
52 Week Range₹828.80 - ₹2,389.70₹1,548.00 - ₹1,916.60
% from 52W High-1.87%-6.68%
All-Time High₹2,389.70 (Jun 01, 2026)₹1,960.35 (Sep 30, 2024)
% from All-Time High-1.87%-8.77%
Growth Metrics
Quarterly Revenue Growth0.46%0.14%
Quarterly Earnings Growth0.88%0.16%
Financial Health
Profit Margin (TTM) i0.12%0.19%
Operating Margin (TTM) i0.21%0.26%
Return on Equity (TTM) i0.15%0.15%
Debt to Equity (MRQ) i38.296.68
Cash & Liquidity
Book Value per Share (MRQ)₹279.50₹324.46
Cash per Share (MRQ)₹32.82₹115.87
Operating Cash Flow (TTM) i₹387.34M₹110.84B
Levered Free Cash Flow (TTM) i₹398.45M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend i₹0.00₹16.50

Valuation & Enterprise Metrics Analysis: Kwality Pharmaceuticals Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricKPL (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i30.8636.73
Forward P/E iN/A29.48
PEG Ratio i0.353.59
Price to Sales (TTM) i3.787.05
Price to Book (MRQ) i6.025.15
Market Capitalization
Market Capitalization i₹17.47B₹3.88T
Enterprise Value i₹18.21B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i3.956.66
Enterprise to EBITDA i17.2823.61
Risk & Other Metrics
Beta i0.130.11
Book Value per Share (MRQ) i₹279.50₹324.46

Financial Statements Comparison: Kwality Pharmaceuticals Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricKPL (2025)SUNPHARMA (2025)
Revenue/Sales i3.70B520.41B
Cost of Goods Sold i1.87B121.98B
COGS % of Revenue i50.6%23.4%
Gross Profit i1.83B398.44B
Gross Margin i49.4%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i620.98M125.81B
Operating Margin i16.8%24.2%
EBITDA i822.79M167.25B
EBITDA Margin i22.2%32.1%
Pre-Tax Income i541.40M137.52B
Pre-Tax Income % of Revenue i14.6%26.4%
Income Tax i143.37M27.72B
Income Tax % of Revenue i3.9%5.3%
Net Income (Profit) i398.03M109.65B
Profit Margin i10.8%21.1%

Balance Sheet & Liquidity Metrics

MetricKPL (2025)SUNPHARMA (2025)
Cash & Equivalents i120.20M102.69B
Total Current Assets i2.84B526.24B
Total Current Assets % of Revenue i76.7%101.1%
Total Current Liabilities i1.70B181.94B
Total Current Liabilities % of Revenue i45.8%35.0%
Long-Term Debt i151.19M3.58B
Long-Term Debt % of Revenue i4.1%0.7%
Total Shareholders Equity i2.62B724.86B
Retained Earnings i2.44B578.62B
Retained Earnings % of Revenue i66.0%111.2%
Property, Plant & Equipment i458.28M100.36B

Cash Flow Statement Comparison

MetricKPL (2025)SUNPHARMA (2025)
Operating Cash Flow i387.34M110.84B
Operating Cash Flow % of Revenue i10.5%21.3%
Capital Expenditures i-232.17M-20.68B
Free Cash Flow i277.15M119.44B
FCF Margin i7.5%23.0%
Debt Repayment i-133.57M-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricKPLSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.38M2.40B
Float Shares i2.30M1.07B
% Held by Insiders i103.85%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i-3.85%15.69%

Dividend Analysis & Yield Comparison: Kwality Pharmaceuticals Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricKPLSUNPHARMA
Last 12-Month Dividend i₹0.00₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend i₹0.00₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends i₹0.00₹52.00
Ex-Dividend DateN/AFeb 05, 2026